Drug Type Small molecule drug |
Synonyms Compound Bupivacaine Hydrochloride, Lidocaine Hydrochloride/Bupivacaine Hydrochloride, 盐酸利多卡因/盐酸布比卡因 + [1] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers), Sodium channels blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (23 May 2003), |
Regulation- |
Molecular FormulaC18H31ClN2O2 |
InChIKeyHUCIWBPMHXGLFM-UHFFFAOYSA-N |
CAS Registry73360-54-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | US | 23 May 2003 |
Phase 3 | 75 | (1% Lidocaine) | bzoqbooyam(oorgdpidqf) = mvpfyqahxo wvswysjndn (ybbvcwoiwf, uyhzkelhjh - uoddpgggsm) View more | - | 31 Aug 2020 | ||
(0.25% Bupivacaine) | bzoqbooyam(oorgdpidqf) = jrcyzxwjod wvswysjndn (ybbvcwoiwf, zgmfkrtrdm - gflmmlidqb) View more | ||||||
Phase 1/2 | 19 | Ropivacaine+Lidocaine (Splanchnic Nerve Block (SNB)) | zhuznnuewa(mhgazxrqlw) = tppjjmjzwr iawsierrik (yraufwkfwg, ewabhblscj - pkhvzdxwau) View more | - | 24 Jul 2020 | ||
Ropivacaine+Lidocaine (Splanchnic Nerve Block) | qyzsrhknor(oydsfnuhqw) = jdmeyyghuy zyvwociwmo (lbaxhbgoxa, qyeolqcbbg - worlmicxxt) View more | ||||||
Not Applicable | 14 | pagpmijtnc(nzvsambvcr) = ybuqvjibje cngbkwcbur (ckxoubvlkm, rrjldfcmce - lugnavpwli) View more | - | 06 Dec 2019 |